Multiple epigenetic factors predict the attention deficit/hyperactivity disorder among the Chinese Han children

Journal of Psychiatric Research

Volumn 64, Issue , 2015, Pages 40-50

  Xu, Yi ^a   Chen, Xiang Tao ^b   Luo, Man ^a   Tang, Yuqing ^a   Zhang, Guangxiang ^c   Wu, De ^b   Yang, Bin ^d   Ruan, Di Yun ^a,e   Wang, Hui Li ^a  

^a HEFEI UNIVERSITY OF TECHNOLOGY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF HAWAII   (United States)

^d Department of Pediatric Surgery   (China)

^e UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

ADHD; DNA methylation; Epigenetic; Histone acetylation; MeCP2

Indexed keywords

ACYLTRANSFERASE; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE TRANSPORTER; E1A ASSOCIATED P300 PROTEIN; HISTONE DEACETYLASE 1; METHYL CPG BINDING PROTEIN 2; DNA MODIFICATION METHYLASE CCRM; DOPAMINE RECEPTOR; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; KAT6B PROTEIN, HUMAN; LEAD; MECP2 PROTEIN, HUMAN; MESSENGER RNA; SITE SPECIFIC DNA METHYLTRANSFERASE (ADENINE SPECIFIC); SLC6A3 PROTEIN, HUMAN;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHINESE; CLINICAL ARTICLE; DNA METHYLATION; DSM-IV; EPIGENETICS; FEMALE; HISTONE ACETYLATION; HUMAN; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURED INTERVIEW; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHEMICALLY INDUCED; CHINA; CPG ISLAND; ETHNOLOGY; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHINA; CPG ISLANDS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EPIGENESIS, GENETIC; FEMALE; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HUMANS; LEAD; LOGISTIC MODELS; MALE; METHYL-CPG-BINDING PROTEIN 2; RECEPTORS, DOPAMINE; RISK FACTORS; RNA, MESSENGER; SEX FACTORS; SITE-SPECIFIC DNA-METHYLTRANSFERASE (ADENINE-SPECIFIC); STATISTICS AS TOPIC;

EID: 84928204730     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.03.006     Document Type: Article

References (41)

1. Aguiar A., Eubig P.A., Schantz S.L. Attention deficit/hyperactivity disorder: a focused overview for children's environmental health researchers. Environ Health Perspect 2010, 118:1646-1653.
2. Archer T., Oscar-Berman M., Blum K. Epigenetics in developmental disorder: ADHD and endophenotypes. JGenet Syndr Gene Ther 2011, 2.
3. Bromberg A., Levine J., Nemetz B., Belmaker R.H., Agam G. No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients. Schizophr Res 2008, 101:50-57.
4. Brown K. Neuroscience. New attention to ADHD genes. Science 2003, 301:160-161.
5. Cai C., Langfelder P., Fuller T.F., Oldham M.C., Luo R., van den Berg L.H., et al. Is human blood a good surrogate for brain tissue in transcriptional studies?. BMC Genomics 2010, 11:589.
6. Callaway E. Epigenomics starts to make its mark. Nature 2014, 508:22.
7. Carrard A., Salzmann A., Malafosse A., Karege F. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder. JAffect Disord 2011, 132:450-453.
8. Chase K.A., Gavin D.P., Guidotti A., Sharma R.P. Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia. Schizophr Res 2013, 149:15-20.
9. Clark S.J., Statham A., Stirzaker C., Molloy P.L., Frommer M. DNA methylation: bisulphite modification and analysis. Nat Protoc 2006, 1:2353-2364.
10. Docherty S.J., Davis O.S., Haworth C.M., Plomin R., Mill J. Bisulfite-based epityping on pooled genomic DNA provides an accurate estimate of average group DNA methylation. Epigenet Chromatin 2009, 2:3.
11. Eubig P.A., Aguiar A., Schantz S.L. Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect 2010, 118:1654-1667.
12. Faraone S.V., Perlis R.H., Doyle A.E., Smoller J.W., Goralnick J.J., Holmgren M.A., et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1313-1323.
13. Fusar-Poli P., Rubia K., Rossi G., Sartori G., Balottin U. Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis. Am J Psychiatry 2012, 169:264-272.
14. Gong R., Ding C., Hu J., Lu Y., Liu F., Mann E., et al. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science 2011, 333:1642-1646.
15. Grunblatt E., Geissler J., Jacob C.P., Renner T., Muller M., Bartl J., et al. Pilot study: potential transcription markers for adult attention-deficit hyperactivity disorder in whole blood. Atten Deficit Hyperact Disord 2012, 4:77-84.
16. Ilani T., Ben-Shachar D., Strous R.D., Mazor M., Sheinkman A., Kotler M., et al. Aperipheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc Nat Acad Sci U. S. A 2001, 98:625-628.
17. Kamakura S., Iwaki A., Matsumoto M., Fukumaki Y. Cloning and characterization of the 5'-flanking region of the human dopamine D4 receptor gene. Biochem Biophys Res Commun 1997, 235:321-326.
18. Kim P., Choi C.S., Park J.H., Joo S.H., Kim S.Y., Ko H.M., et al. Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring. JNeurosci Res 2014, 92:658-670.
19. Kraft M., Cirstea I.C., Voss A.K., Thomas T., Goehring I., Sheikh B.N., et al. Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice. JClin Investig 2011, 121:3479-3491.
20. Kubota T., Miyake K., Hirasawa T. Epigenetic understanding of gene-environment interactions in psychiatric disorders: a new concept of clinical genetics. Clin Epigenet 2012, 4:1.
21. Luo M., Xu Y., Cai R., Tang Y., Ge M.M., Liu Z.H., et al. Epigenetic histone modification regulates developmental lead exposure induced hyperactivity in rats. Toxicol Lett 2014, 225:78-85.
22. Martel M.M., Nikolas M., Jernigan K., Friderici K., Waldman I., Nigg J.T. The dopamine receptor D4 gene (DRD4) moderates family environmental effects on ADHD. JAbnorm Child Psychol 2011, 39:1-10.
23. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonte B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12:342-348.
24. Mill J., Petronis A. Pre- and peri-natal environmental risks for attention-deficit hyperactivity disorder (ADHD): the potential role of epigenetic processes in mediating susceptibility. JChild Psychol Psychiatry, Allied Discip 2008, 49:1020-1030.
25. Murgatroyd C., Patchev A.V., Wu Y., Micale V., Bockmuhl Y., Fischer D., et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci 2009, 12:1559-1566.
26. Oak J.N., Oldenhof J., Van Tol H.H. The dopamine D(4) receptor: one decade of research. Eur J Pharmacol 2000, 405:303-327.
27. Oh J.E., Chambwe N., Klein S., Gal J., Andrews S., Gleason G., et al. Differential gene body methylation and reduced expression of cell adhesion and neurotransmitter receptor genes in adverse maternal environment. Transl Psychiatry 2013, 3:e218.
28. Philibert R.A., Beach S.R., Lei M.K., Brody G.H. Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Clin Epigenet 2013, 5:19.
29. Pierpont E.I., Tworog-Dube E., Roberts A.E. Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings. Dev Med Child Neurol 2014, 57:385-392.
30. Rosa A., Picchioni M.M., Kalidindi S., Loat C.S., Knight J., Toulopoulou T., et al. Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. Am J Med Genet Part B, Neuropsychiat Genet: Off Publ Int Soc Psychiat Genet 2008, 147B:459-462.
31. Santoro M.L., Santos C.M., Ota V.K., Gadelha A., Stilhano R.S., Diana M.C., et al. Expression profile of neurotransmitter receptor and regulatory genes in the prefrontal cortex of spontaneously hypertensive rats: relevance to neuropsychiatric disorders. Psychiatry Res 2014, 219:674-679.
32. Schmitt A., Malchow B., Hasan A., Falkai P. The impact of environmental factors in severe psychiatric disorders. Front Neurosci 2014, 8:19.
33. Sharma A., Couture J. Areview of the pathophysiology, etiology, and treatment of attention-deficit hyperactivity disorder (ADHD). Ann Pharmacother 2014, 48:209-225.
34. Sun H., Kennedy P.J., Nestler E.J. Epigenetics of the depressed brain: role of histone acetylation and methylation. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 2013, 38:124-137.
35. Thapar A., Langley K., Owen M.J., O'Donovan M.C. Advances in genetic findings on attention deficit hyperactivity disorder. Psychol Med 2007, 37:1681-1692.
36. van Mil N.H., Steegers-Theunissen R.P., Bouwland-Both M.I., Verbiest M.M., Rijlaarsdam J., Hofman A., et al. DNA methylation profiles at birth and child ADHD symptoms. JPsychiat Res 2014, 49:51-59.
37. Wang H.L., Chen X.T., Yang B., Ma F.L., Wang S., Tang M.L., et al. Case-control study of blood lead levels and attention deficit hyperactivity disorder in Chinese children. Environ Health Perspect 2008, 116:1401-1406.
38. Warnecke P.M., Stirzaker C., Song J., Grunau C., Melki J.R., Clark S.J. Identification and resolution of artifacts in bisulfite sequencing. Methods 2002, 27:101-107.
39. Xu X., Mill J., Sun B., Chen C.K., Huang Y.S., Wu Y.Y., et al. Association study of promoter polymorphisms at the dopamine transporter gene in attention deficit hyperactivity disorder. BMC Psychiatry 2009, 9:3.
40. Zhou M., Rebholz H., Brocia C., Warner-Schmidt J.L., Fienberg A.A., Nairn A.C., et al. Forebrain overexpression of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD. Proc Nat Acad Sci U. S. A 2010, 107:4401-4406.
41. Zvara A., Szekeres G., Janka Z., Kelemen J.Z., Cimmer C., Santha M., et al. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers. Dis Markers 2005, 21:61-69.